Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)

SHE:300204 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 20, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,271	3,540	4,854	6,419	8,242	4,241
Market Cap Growth	296.68%	-27.07%	-24.38%	-22.12%	94.35%	-18.80%
Enterprise Value	14,144	3,498	4,711	6,113	7,806	3,550
Last Close Price	29.87	7.41	10.16	13.60	17.55	9.03
Forward PE	-	78.50	78.50	78.50	78.50	78.50
PS Ratio	58.40	10.90	13.33	11.69	14.11	9.97
PB Ratio	16.60	3.86	4.76	4.74	5.32	2.67
P/TBV Ratio	17.53	4.05	5.03	5.12	5.70	2.86
EV/Sales Ratio	57.88	10.77	12.94	11.14	13.36	8.35
Debt / Equity Ratio	0.05	0.05	0.04	0.02	0.01	0.03
Net Debt / Equity Ratio	-0.13	-0.01	-0.04	-0.17	-0.30	-0.42
Net Debt / EBITDA Ratio	2.05	0.51	0.13	1.17	2.23	4.35
Net Debt / FCF Ratio	0.66	0.13	0.17	1.02	2.10	4.13
Asset Turnover	0.19	0.26	0.24	0.31	0.32	0.23
Inventory Turnover	2.13	2.89	3.75	4.64	3.69	1.74
Quick Ratio	1.65	0.61	0.71	1.96	3.18	4.09
Current Ratio	2.46	1.15	1.15	2.28	3.50	4.34
Return on Equity (ROE)	-18.63%	-15.25%	-33.60%	-13.56%	-8.76%	-8.25%
Return on Assets (ROA)	-3.55%	-2.24%	-15.56%	-8.36%	-8.13%	-6.38%
Return on Invested Capital (ROIC)	-8.74%	-4.73%	-35.68%	-21.17%	-23.89%	-21.02%
Return on Capital Employed (ROCE)	-6.30%	-4.50%	-33.20%	-16.30%	-14.70%	-11.50%
Earnings Yield	-1.16%	-4.09%	-8.22%	-3.07%	-1.67%	-3.14%
FCF Yield	-1.24%	-2.46%	-5.37%	-3.62%	-2.65%	-3.85%
Buyback Yield / Dilution	-9.55%	-1.67%	1.17%	-1.42%	0.27%	-4.41%
Total Shareholder Return	-9.55%	-1.67%	1.17%	-1.42%	0.27%	-4.41%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.